Skip to main content
. Author manuscript; available in PMC: 2021 Mar 15.
Published in final edited form as: Expert Rev Precis Med Drug Dev. 2020 Aug 11;5(5):371–382. doi: 10.1080/23808993.2020.1803062

Table 1:

Altered expression of CRAC channel proteins and their reported effects in different types of cancers

Cancer type Cancer model Change in expression of CARC channel protein Effect Reference
Breast Microarray profiles of 295 human breast tumors High STIM1, low STIM2 Associated with poor prognosis 45
Breast MDA-MB-231, MC-7, T47D, BT-483 Elevated Orai1 Remodeling of Ca2+ influx associated with invasive stimuli 45
Breast MCF-7 cells and cancerous breast tissue samples High Orai3 expression Promotes cell proliferation, cell cycle progression and apoptosis resistance 49
Cervical cancer primary cervical cancer tissues Overexpression of STIM1 Reduces five-year survival rate; Promotes tumor cell growth, cell cycle progression, migration, invasion and angiogenesis 50
Ovarian cancer A2780cis (cisplatin resistant) cells High Orai1 and STIM1 expression Contributes to therapy resistance 52
Renal Cancer ccRCC tissues High expression of Orai1 Promotes cell proliferation and migration 53
Colorectal cancer Patient tumor tissue specimen STIM1 overexpression Increases tumor size, invasion and migration 54
Colorectal cancer SW620 and LOVO cells STIM1 overexpression Promotes metastasis and EMT 55
Colorectal cancer Tissue microarray of 90 CRC patients STIM1 overexpression Indicative of poor prognosis 55
Gastric cancer Tumor tissues from 327 GC patients High Orai and STIM1 expression Correlates with frequent recurrence and high mortality rate 57
Liver cancer Hepatoma tissues and HCC cell lines Higher expression of STIM1 Correlates with high metastatic potential in patients and higher migration ability in cell lines 58
Liver cancer Hepatocarcinoma tissues Elevated Orai1 expression Serves as predictor of 5-FU sensitivity 59
Pancreatic cancer Panc-1 cells High expression of Orai1 and STIM1 Contributes to apoptosis resistance 60
Esophageal cancer Tumor tissues from ESCC patients Elevated expression of Orai1 Linked to poor overall and recurrence-free survival 61
Lung cancer NSCLC tumor tissues Higher STIM1 expression Promotes tumorigenesis 62
Lung cancer Tumor samples from 60 lung adenocarcinoma patients Orai3 overexpression Correlates with high tumor grade 63
Glioblastoma U251 cells Higher expression of STIM1 Promotes cell proliferation and invasion 65
Glioblastoma Primary human cell lines established from glioblastoma surgical samples Increased Orai1 levels Promotes cell invasion 66
Glioblastoma Tumor tissues from 61 glioma patients Elevated Orai expression Correlates with high tumor grade 67
Glioblastoma Human glioma cell lines U251, SNB19, U87, and LN229 Elevated Orai expression Promotes cell migration and invasion 67
Leukemia HL60 cells High expression of Orai2 Promotes cell migration 68
Multiple myeloma Tumor tissues from 60 Multiple Myeloma patients Increased expression of STIM1 and Orai1 Associated with poor prognosis 69
Multiple myeloma KM3 and U266 cells Increased expression of STIM1 and Orai1 Promotes cell growth and apoptosis resistance 69